Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells by Joyce M. van Dodewaard-de Jong, Saskia JAM Santegoets, Peter M. van de Ven, Jurjen Versluis, Henk M. W. Verheul, Tanja D. de Gruijl, Winald R. Gerritsen, Alfons J. M. van den Eertwegh

Get full text

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment by Sjoerd O Klaver, André N Vis, Gerard Vreugdenhil, Haiko J Bloemendal, Pieter L van den Berg, Niven Mehra, Mathijs P Hendriks, Tessa van Elst, Sjaak Bloem, Zarina Lalmahomed, Daphne Luijendijk, Jean-Paul A van Basten, Roderick CN van den Bergh, Joyce M van Dodewaard-de Jong, Addy CM van de Luijtgaarden, Luc AJ Roelofs, Eric HJEJ Vrijhof, Bart P Wijsman, Peter FA Mulders

Get full text